Search Results

Executive leader brings industrial biotech expertise from Corbion, LS9 and Genencor to scale the Fine Mycelium™ technology platform.

Film Premiere Highlights Chef’s Journey to Discover the Impact of AlgaPrime™ DHA on Sustainable Aquaculture

Evotec SE announced the appointment of Aurélie Dalbiez as the Company’s new Chief People Officer, effective 15 June 2024.

A new meta-study report commissioned by Holland Bioplastics, an association advancing bioplastics knowledge worldwide, concludes that the fundamental characteristics of polylactic acid (PLA), a biobased polymer made entirely from fermented plant sugars, and the hydrolysis process indicate that PLA does not produce persistent microplastics.

PADM Medical PRECISION ECO™ Plant based procedural mask with earloops receives emergency use authorization (EUA) from the U.S. FDA – It is the world’s first plant based procedural mask to receive EUA for use in medical and healthcare settings.

Evotec SE announced financial results and corporate updates for the first quarter 2024.

Evotec SE reported financial results and corporate updates for the fiscal year ended 31 December 2023 and announced a priority reset to optimise its business to meet evolving market demand and focus on profitable growth in 2024 and beyond.

The Phase 3 study conducted in the U.S. will assess the efficacy and safety of the first subcutaneous long-acting Injectable (LAI) formulation of olanzapine for the treatment of patients with schizophrenia.

The study conducted in 399 participants met its primary efficacy endpoint with a reduction of 72% of COVID-19 infection in the group treated with daily oral administration of ivermectin compared to the placebo group.